Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$3.63M Buy
42,300
+23,700
+127% +$2.13M 0.02% 957
2018
Q1
$1.61M Sell
18,600
-1,100
-6% -$85.4K 0.01% 1546
2017
Q4
$1.36M Buy
+19,700
New +$1.29M 0.01% 1686
2017
Q1
Sell
-2,000
Closed -$75K 4846
2016
Q4
$75K Hold
2,000
﹤0.01% 4022
2016
Q3
$82K Buy
+2,000
New +$79.1K ﹤0.01% 3682
2015
Q2
Sell
-25,000
Closed -$834K 5372
2015
Q1
$834K Buy
25,000
+13,900
+125% +$469K 0.01% 2069
2014
Q4
$511K Sell
11,100
-12,500
-53% -$535K ﹤0.01% 2566
2014
Q3
$870K Buy
+23,600
New +$862K 0.01% 1941
2013
Q4
Sell
-16,400
Closed -$297K 5331
2013
Q3
$297K Buy
16,400
+100
+0.6% +$3.36K ﹤0.01% 3308
2013
Q2
$512 Buy
+16,300
New +$462K ﹤0.01% 2757

Other funds holding PODD

PEAK6 Group's PODD Position: Q2 2018 in Review

PEAK6 Group opened a new position in Insulet (PODD) in Q2 2018: 1,357 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #3643 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in PODD as recently as Q4 2016.

PEAK6 Group first reported a position in PODD in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.03M in Q2 2016. 239 funds tracked by Wall St. Rank hold PODD as of Q2 2018.

  • PEAK6 Group held 1,357 shares of Insulet worth $116K as of Q2 2018.
  • Insulet was a new PEAK6 Group position in Q2 2018.
  • Insulet made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3643 holding.
  • PEAK6 Group first reported a position in Insulet in Q2 2013 and has held it in 6 quarters since.
  • PEAK6 Group's Insulet position peaked at $1.03M in Q2 2016.
  • 239 funds tracked by Wall St. Rank held Insulet as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.